摘要:
An external preparation, for the treatment of dysuria or lower urinary tract disease, which comprises
1) at least one compound selected from amusulosin and salts thereof; 2) aqueous alcohol, and 3) at least one transdermal absorption promoting agent selected from aliphatic dicarboxylic acid diesters, nicotinic acid esters and isonicotinic acid esters, with or without addition of a terpene.
摘要翻译:一种用于治疗排尿困难或下尿路疾病的外用制剂,其包含1)至少一种选自阿莫苏洛辛及其盐的化合物; 2)含水醇,以及3)至少一种选自脂肪族二羧酸二酯,烟酸酯和异烟酸酯的透皮吸收促进剂,有或无添加萜烯。 ü
摘要:
A solid microdose drug preparation containing particles of microdose drug such as formoterol fumarate or β-methyldigoxin coated with wax. The wax coating considerably improves the stability and the content uniformity of the microdose drug in the preparation.
摘要:
A device for extended retention in the stomach, the device comprising a molding which comprises shape memory material (A) joined to or mixed with material erodible in vivo (B), said molding being of a size, shape and durability to remain in the stomach for a definite residence time. The device can be of a shape such as not to hinder passage of food in the stomach and is capable of being folded to an orally administrable form. It is used for drug delivery.
摘要:
A plaster structure for iontophoresis comprising an electrode layer (4) and a medicament-containing layer (1), wherein a water supplying layer - composed of a water-containing lamina (2) and/or a water-containing self-adhesive lamina (3) - is formed between the electrode layer (4) and the medicament-containing layer (1), and further a sealing cover (5) is formed at the outside of the electrode layer (4).
摘要:
A transdermal formulation of nicardipine hydrochloride which comprises [a] a transdermal formulation base compounded with [b] nicardipine hydrochloride dissolved or suspended in a liquid containing a urea and at least one compound selected from propylene glycol, monohydric alcohols having 2 to 4 carbon atoms, lactic acid, thioglycol, middle chain fatty acid glycerides and sorbitan middle chain fatty acid esters. Such formulations give improved percutaneous absorption of the nicardipine hydrochloride. Inclusion in the formulation of crystallizing inhibitor for nicardipine hydrochloride can improve the stability of the formulation.
摘要:
This invention provides a medicinal patch comprising a solution or suspension of drug component and penetration enhancer dispersed in a base selected predominantly from cacao butter, isocacao butter and triglycerides of C 12 to C 18 vegetable saturated fatty acids. This patch composition is usually provided in a shallow dish for adhering to the skin.
摘要:
A device for extended retention in the stomach, the device comprising a molding which comprises shape memory material (A) joined to or mixed with material erodible in vivo (B), said molding being of a size, shape and durability to remain in the stomach for a definite residence time. The device can be of a shape such as not to hinder passage of food in the stomach and is capable of being folded to an orally administrable form. It is used for drug delivery.